J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Disclosure under regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Audio recording of Investors/analysts call with Management
J B Chemicals & Pharmaceuticals Results Earnings Call for Q3FY23
Conference Call with J B Chemicals & Pharmaceuticals Management and Analysts on Q3FY23 Performance and Outlook. Listen to the full earnings transcript. J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper cutting of extract of consolidated financial results for quarter ended on December 31, 2022
JB Chemicals declares 8.50 per share dividend, posts 32% revenue growth in Q3
A mid-size company with a market valuation of 15,748.86 Cr, J.B. Chemicals & Pharmaceuticals Ltd operates in the pharmaceutical industry. J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of duplicate share certificates - Intimation under regulation 39(3) the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Investor Presentation
Enclosed please find the presentation the Company proposes to make to investors/analysts on performance of the Company for the quarter ended on December 31, 2022. J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Enclosed please find press release the Company proposes to issue on unaudited consolidated financial results for the quarter ended on December 31, 2022. J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Intimation Of Record Date Pursuant To Regulation 42 Of The Securities & Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
The Company has fixed Saturday, February 18, 2023 as record date, to ascertain eligibility of the beneficial owners/shareholders of the Company to receive the interim dividend for FY 2022-2023 J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Corporate Action-Board approves Dividend
Declaration of interim dividend of Rs. 8.50 per share of FV Rs. 2 (425%) for FY 2022-2023 J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors - Unaudited Financial Results For The Quarter Ended December 31, 2022
Unaudited Financial Results for the quarter ended December 31, 2022